Understanding What are Neurokinin-3 Receptor Antagonist Drugs?
•
5 min read
Affecting up to 80% of women during menopause, vasomotor symptoms (VMS) like hot flashes often prompt a search for alternative treatments. Neurokinin-3 receptor antagonist drugs, a novel non-hormonal option, specifically target and block a key signaling pathway in the brain's thermoregulatory center.
